Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma
specificStage II cutaneous T-cell lymphoma may be either of the following: (1) stage IIA, in which the skin has red, dry, scaly patches but no tumors, and lymph nodes are enlarged but do not contain cancer cells; (2) stage IIB, in which tumors are found on the skin, and lymph nodes are enlarged but do not contain cancer cells.
9
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma(9)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 55.6 |
| 2 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive | 55.6 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 55.6 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 55.6 |
| 5 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 55.6 |
| 6 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 55.6 |
| 7 | Cleveland Clinic Cancer CenterCleveland, OH | 55.6 |
| 8 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 55.6 |
| 9 | University of Illinois Cancer CenterChicago, IL | 55.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →